ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $33,000 | -76.3% | 1,185 | -73.1% | 0.00% | – |
| Q4 2020 | $139,000 | -93.4% | 4,413 | -92.8% | 0.00% | -100.0% |
| Q3 2020 | $2,120,000 | -50.2% | 60,999 | -25.8% | 0.00% | -50.0% |
| Q2 2020 | $4,253,000 | +22284.2% | 82,241 | +14202.8% | 0.00% | – |
| Q1 2020 | $19,000 | -91.5% | 575 | -84.7% | 0.00% | – |
| Q4 2019 | $224,000 | +121.8% | 3,762 | +36.2% | 0.00% | – |
| Q3 2019 | $101,000 | -19.2% | 2,762 | +3.4% | 0.00% | – |
| Q2 2019 | $125,000 | +443.5% | 2,671 | +364.5% | 0.00% | – |
| Q1 2019 | $23,000 | -43.9% | 575 | -36.0% | 0.00% | – |
| Q4 2018 | $41,000 | +24.2% | 898 | +22.5% | 0.00% | – |
| Q3 2018 | $33,000 | +13.8% | 733 | -0.7% | 0.00% | – |
| Q2 2018 | $29,000 | -31.0% | 738 | +28.3% | 0.00% | – |
| Q1 2018 | $42,000 | -91.6% | 575 | -92.4% | 0.00% | – |
| Q4 2017 | $500,000 | +525.0% | 7,596 | +375.9% | 0.00% | – |
| Q3 2017 | $80,000 | +185.7% | 1,596 | +167.8% | 0.00% | – |
| Q2 2017 | $28,000 | -88.0% | 596 | -91.0% | 0.00% | – |
| Q1 2017 | $233,000 | +3783.3% | 6,596 | +1006.7% | 0.00% | – |
| Q4 2016 | $6,000 | -40.0% | 596 | -14.1% | 0.00% | – |
| Q3 2016 | $10,000 | -95.3% | 694 | -96.8% | 0.00% | – |
| Q2 2016 | $215,000 | +43.3% | 21,735 | +144.2% | 0.00% | – |
| Q1 2016 | $150,000 | +4.2% | 8,901 | +36.7% | 0.00% | – |
| Q4 2015 | $144,000 | +1500.0% | 6,512 | +1600.3% | 0.00% | – |
| Q3 2015 | $9,000 | -55.0% | 383 | +53.2% | 0.00% | – |
| Q2 2015 | $20,000 | -91.7% | 250 | -90.4% | 0.00% | – |
| Q1 2015 | $241,000 | +588.6% | 2,604 | +204.9% | 0.00% | – |
| Q4 2014 | $35,000 | +66.7% | 854 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | +950.0% | 854 | +676.4% | 0.00% | – |
| Q2 2014 | $2,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |